Brain Tumor Drugs Market To Reach USD 5.25 Billion By 2032, Driven By Advances In Targeted Therapies And Immunotherapies Increasing demand for personalized treatment approaches & the growing ...
Nov. 12, 2024 — Glioblastoma is the most common kind of malignant braintumor in adults. So far, no treatment has been able to make this aggressive tumor permanently disappear. The tumor cells ...